ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The industrial biotechnology start-up Botanical Solution has added $7 million to the series A funding round it initially closed in January 2022, for a total of $13 million. The add-on fundraising was led by Otter Capital and was based on a partnership the start-up struck in May with Croda to develop a cell-culture based route to QS-21, an oligosaccharide used in vaccines, including for COVID-19. QS-21 is otherwise extracted from a rare tree species found mostly in Chile.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X